Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthritis.
Age Factors
Body Mass Index
Cohort Studies
Comorbidity
Databases, Factual
Demography
Depressive Disorder
/ epidemiology
Female
Health Status
Humans
Male
Middle Aged
North America
/ epidemiology
Nutritional Physiological Phenomena
Osteoarthritis
/ epidemiology
Quality of Life
/ psychology
Risk
Sex Factors
Socioeconomic Factors
Surveys and Questionnaires
Depressive symptoms
elderly
functioning
income
network analysis
quality of life
Journal
Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091
Informations de publication
Date de publication:
06 02 2019
06 02 2019
Historique:
pubmed:
31
1
2019
medline:
22
5
2020
entrez:
31
1
2019
Statut:
epublish
Résumé
A complex interaction exists between age, body mass index, medical conditions, polypharmacotherapy, smoking, alcohol use, education, nutrition, depressive symptoms, functioning and quality of life (QoL). We aimed to examine the inter-relationships among these variables, test whether depressive symptomology plays a central role in a large sample of adults, and determine the degree of association with life-style and health variables. Regularised network analysis was applied to 3532 North-American adults aged ⩾45 years drawn from the Osteoarthritis Initiative. Network stability (autocorrelation after case-dropping), centrality of nodes (strength, M, the sum of weight of the connections for each node), and edges/regularised partial correlations connecting the nodes were assessed. Physical and mental health-related QoL (M = 1.681; M = 1.342), income (M = 1.891), age (M = 1.416), depressive symptoms (M = 1.214) and education (M = 1.173) were central nodes. Depressive symptoms' stronger negative connections were found with mental health-related QoL (-0.702), income (-0.090), education (-0.068) and physical health-related QoL (-0.354). This latter was a 'bridge node' that connected depressive symptoms with Charlson comorbidity index, and number of medications. Physical activity and Mediterranean diet adherence were associated with income and physical health-related QoL. This latter was a 'bridge node' between the former two and depressive symptoms. The network was stable (stability coefficient = 0.75, i.e. highest possible value) for all centrality measures. A stable network exists between life-style behaviors and social, environmental, medical and psychiatric variables. QoL, income, age and depressive symptoms were central in the multidimensional network. Physical health-related QoL seems to be a 'bridge node' connecting depressive symptoms with several life-style and health variables. Further studies should assess such interactions in the general population.
Identifiants
pubmed: 30698512
pii: S204579601800077X
doi: 10.1017/S204579601800077X
pmc: PMC8061212
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14Commentaires et corrections
Type : ErratumIn
Références
J Affect Disord. 2018 Aug 1;235:39-44
pubmed: 29649709
Psychol Med. 2017 Dec;47(16):2906-2917
pubmed: 28637534
Nutr Metab Cardiovasc Dis. 2006 Dec;16(8):559-68
pubmed: 17126772
CNS Drugs. 2013 May;27 Suppl 1:S5-10
pubmed: 23712795
PLoS One. 2013 Jun 24;8(6):e67133
pubmed: 23826212
Psychophysiology. 2016 Mar;53(3):415-24
pubmed: 26877135
Acta Psychiatr Scand. 2017 May;135(5):373-387
pubmed: 28122130
Acta Psychiatr Scand. 2016 Dec;134(6):546-556
pubmed: 27704532
Curr Psychiatry Rep. 2015 May;17(5):30
pubmed: 25773226
Curr Pharm Des. 2016;22(40):6087-6106
pubmed: 27669970
J Affect Disord. 2014 Sep;166:173-8
pubmed: 25012428
JAMA Psychiatry. 2018 Apr 1;75(4):396-404
pubmed: 29450447
World Psychiatry. 2017 Jun;16(2):163-180
pubmed: 28498599
Am J Clin Nutr. 2016 Nov;104(5):1403-1409
pubmed: 27680996
J Gerontol A Biol Sci Med Sci. 2001 Oct;56 Spec No 2:23-35
pubmed: 11730235
J Affect Disord. 2018 Feb;227:323-329
pubmed: 29132075
World Psychiatry. 2014 Feb;13(1):28-35
pubmed: 24497240
Addiction. 2014 Jun;109(6):1022-30
pubmed: 24552489
J Affect Disord. 2016 Jun;197:259-67
pubmed: 26999550
Annu Rev Clin Psychol. 2013;9:91-121
pubmed: 23537483
Exp Gerontol. 2015 Apr;64:8-16
pubmed: 25639944
J Health Serv Res Policy. 2013 Jan;18(1):21-7
pubmed: 23393038
Age Ageing. 2017 May 1;46(3):470-476
pubmed: 27932358
Phys Ther. 2017 Jun 1;97(6):659-668
pubmed: 28201628
Nord J Psychiatry. 2014 Oct;68(7):507-12
pubmed: 24476587
Int J Environ Res Public Health. 2016 Jul 09;13(7):
pubmed: 27409627
Behav Res Methods. 2018 Feb;50(1):195-212
pubmed: 28342071
Med Care. 1996 Jan;34(1):73-84
pubmed: 8551813
Am J Clin Nutr. 2017 Jul;106(1):162-167
pubmed: 28592612
Health Econ. 2018 Mar;27(3):525-544
pubmed: 28990318
Ageing Res Rev. 2017 Jul;36:78-87
pubmed: 28366616
Clin Nutr. 2018 Oct;37(5):1492-1497
pubmed: 28918168
Mol Psychiatry. 2019 Jan;24(1):18-33
pubmed: 29453413
Arthritis. 2012;2012:698709
pubmed: 23082249
PLoS One. 2011;6(5):e19590
pubmed: 21611123
Psychol Med. 2017 Sep;47(12):2107-2117
pubmed: 28374652
Eur J Clin Nutr. 2012 Mar;66(3):360-8
pubmed: 21847137
Br J Psychiatry. 2018 Apr;212(4):215-221
pubmed: 29506597
Int J Health Serv. 2015;45(4):657-78
pubmed: 25995305
Gen Hosp Psychiatry. 2015 Jan-Feb;37(1):14-23
pubmed: 25510845
Sci Rep. 2017 Aug 16;7(1):8430
pubmed: 28814728
Psychiatry Res. 2018 Jun;264:254-259
pubmed: 29655968
J Affect Disord. 2018 Mar 15;229:231-238
pubmed: 29329054
Ther Clin Risk Manag. 2017 Jun 29;13:757-777
pubmed: 28721057
Health Serv Res. 2000 Oct;35(4):885-904
pubmed: 11055454
Am J Psychiatry. 2014 Apr;171(4):395-7
pubmed: 24687194
Bull World Health Organ. 2003;81(9):646-56
pubmed: 14710506
J Psychiatr Res. 2018 Aug;103:142-149
pubmed: 29852421
BMJ. 2009 Feb 02;338:a3079
pubmed: 19188214
Soc Sci Med. 2014 Nov;120:21-30
pubmed: 25215933
J Clin Psychiatry. 2000 Jan;61(1):9-15
pubmed: 10695639
Psychiatry Res. 2016 Jul 30;241:47-54
pubmed: 27155287
PLoS One. 2017 Sep 5;12(9):e0184268
pubmed: 28873469
Exp Clin Psychopharmacol. 2018 Apr;26(2):138-146
pubmed: 29389212
Med Care. 1994 Jun;32(6):551-67
pubmed: 8189774
Br J Psychiatry. 2014 Dec;205(6):428-35
pubmed: 25452600
PLoS One. 2016 Feb 01;11(2):e0146303
pubmed: 26828901
Sci Rep. 2017 Aug 8;7(1):7597
pubmed: 28790418
Qual Life Res. 2013 Jun;22(5):951-6
pubmed: 22678354
J Bras Nefrol. 2014 Jul-Sep;36(3):332-8
pubmed: 25317616
Can J Psychiatry. 1984 Oct;29(6):461-6
pubmed: 6488125
Psychiatry Res. 2016 Jul 30;241:289-96
pubmed: 27209359
Curr Opin Psychiatry. 2005 Mar;18(2):189-93
pubmed: 16639173
Eur Psychiatry. 2017 Oct;46:42-47
pubmed: 28992535
Med Hypotheses. 2006;67(2):362-70
pubmed: 16542786
World Psychiatry. 2016 Jun;15(2):166-74
pubmed: 27265707
PLoS One. 2014 Apr 10;9(4):e94563
pubmed: 24722559
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Addict Behav. 2014 Oct;39(10):1418-29
pubmed: 24935795
Clin Nutr. 2017 Dec;36(6):1609-1614
pubmed: 27769781